<DOC>
	<DOCNO>NCT00947375</DOCNO>
	<brief_summary>The purpose study determine effect lamotrigine augmentation Haloperidol decanoate treatment Resistant Schizophrenia predominantly verbal resistant hallucinosis : A randomized , double-blind , placebo-controlled , study . Nadir A.Aliyev &amp; Zafar N.Aliyev Central Mental Clinic Outpatients Baku city Azerbaijan Republic Abstract : OBJECTIVE : The current paper report double-blind , randomize study role lamotrigine augmentation agent haloperidol decanoate treatment patient 's schizophrenia verbal resistant hallucinosis .</brief_summary>
	<brief_title>Lamictal TM , Haloperidol Decanoate Schizophrenia</brief_title>
	<detailed_description>METHOD : A structured clinical interview , DSM-IV Axis I Disorder , Patient Edition , use diagnose schizophrenia accord DSM-IV . Three hundred fifty patient study . The patient randomly divide two group 175 subject group . First group patient receive either haloperidol deaconate 50 mg weekly intramuscular lamotrigine 150-200 mg day per 12 week . Second group patient give haloperidol deaconate 50 mg weekly intramuscular placebo per o 12 week . Data clinical assessment collect week 0 , 6 12 week . The expressiveness psychopathology estimate PANSS . Test response group define reduction PANSS use analysis variance chi-square test .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Decanoic acid</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Display acute systemic medical disorder medical disorder require frequent change medication ; Display history seizure , cerebrovascular disease , structural brain damage , trauma , focal neurological sings examination , evidence progressive neurological disorder , substance dependence ( except tobacco ) . age 1860 ; gender ; resistant scizophrenia patient ; previous treatment history ; verbal resistant hallucinosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>lamictal TM</keyword>
	<keyword>haloperidol decanoate</keyword>
</DOC>